Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SHPH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of SHPH by reported 13-F value include CITADEL ADVISORS, BARCLAYS PLC, Tower Research Capital (TRC), based on the most recent SEC filings. SHPH trades on the Nasdaq exchange and files with the SEC under CIK 1757499. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SHPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Shuttle Pharmaceuticals Holdings, Inc. directly from SEC EDGAR.
Net Income
$-2.2M
| Institution | Shares | Value | Reported |
|---|---|---|---|
| CITADEL ADVISORS | 24,354 | $79.2K | 2026-06-30 |
| BARCLAYS PLC | 750 | $2.4K | 2026-06-30 |
| Tower Research Capital (TRC) | 389 | $1.3K | 2026-06-30 |
| KELLEHER FINANCIAL ADVISORS | 120 | $390.00 | 2026-06-30 |
| HRT FINANCIAL | 78,597 | $255.00 | 2026-06-30 |
13F Pro Quality Score
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.